Chesapeake Urology Research Associates

Summary

Chesapeake Urology Research Associates is a medical facility located in Towson, Maryland. This center is recognized for care of Prostate Cancer, Bladder Cancer, Transitional Cell Carcinoma, Neoplasm, Vulval Intraepithelial Neoplasia and other specialties. Chesapeake Urology Research Associates is involved with conducting 34 clinical trials across 27 conditions. There are 2 research doctors associated with this hospital, such as Ronald Tutrone, MD and Richard Levin, MD.

Top PIs

Clinical Trials running at Chesapeake Urology Research Associates

Prostate Cancer

Lu-177 Ludotadipep

for Prostate Cancer

This trial tests the safety and effectiveness of a radioactive drug called [177Lu]Ludotadipep. The drug works by delivering radiation directly to certain cells to treat the condition. Lutetium-177 (177Lu) has been widely used in targeted therapy, particularly in peptide receptor radionuclide therapy (PRRT) for treating neuroendocrine tumors.

Recruiting

2 awards

Phase 1 & 2

Sipuleucel-T

for Prostate Cancer

A multicenter, open-label, prospective study to investigate immune boost response changes in patients with metastatic castrate-resistant prostate cancer (mCRPC).

Recruiting

1 award

Phase 2

3 criteria

Aglatimagene Besadenovec + Valacyclovir

for Prostate Cancer

Phase 2a, open-label, multi-center study evaluating biomarkers and biodistribution of aglatimagene besadenovec plus valacyclovir in men with localized, favorable intermediate-risk prostate cancer who are planning to receive external beam radiation therapy (EBRT).

Recruiting

1 award

Phase 2

4 criteria